Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Payments for research participation: Don't tax the Guinea pig.

Rand, Leah Z; Kesselheim, Aaron S.

Clin Trials ; 19(5): 579-583, 2022 10.

Artigo em Inglês | MEDLINE | ID: mdl-35786008

2.

International Reference Pricing for Prescription Drugs in the United States: Administrative Limitations and Collateral Effects.

Rand, Leah Z; Kesselheim, Aaron S.

Value Health ; 24(4): 473-476, 2021 04.

Artigo em Inglês | MEDLINE | ID: mdl-33840424

3.

The ethics of grandfather clauses in healthcare resource allocation.

Wester, Gry; Gibson Rand, Leah Zoe; Lu, Christine; Sheehan, Mark.

Bioethics ; 35(2): 151-160, 2021 02.

Artigo em Inglês | MEDLINE | ID: mdl-33043477

4.

Public involvement in the governance of population-level biomedical research: unresolved questions and future directions.

Erikainen, Sonja; Friesen, Phoebe; Rand, Leah; Jongsma, Karin; Dunn, Michael; Sorbie, Annie; McCoy, Matthew; Bell, Jessica; Burgess, Michael; Chen, Haidan; Chico, Vicky; Cunningham-Burley, Sarah; Darbyshire, Julie; Dawson, Rebecca; Evans, Andrew; Fahy, Nick; Finlay, Teresa; Frith, Lucy; Goldenberg, Aaron; Hinton, Lisa; Hoppe, Nils; Hughes, Nigel; Koenig, Barbara; Lignou, Sapfo; McGowan, Michelle; Parker, Michael; Prainsack, Barbara; Shabani, Mahsa; Staunton, Ciara; Thompson, Rachel; Varnai, Kinga; Vayena, Effy; Williams, Oli; Williamson, Max; Chan, Sarah; Sheehan, Mark.

J Med Ethics ; 2020 Oct 06.

Artigo em Inglês | MEDLINE | ID: mdl-33023977

5.

The Value of the Quality-Adjusted Life Years.

Willke, Richard J; Pizzi, Laura T; Rand, Leah Z; Neumann, Peter.

Value Health ; 27(6): 702-705, 2024 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-38703994

6.

Understanding and using patient experiences as evidence in healthcare priority setting.

Rand, Leah; Dunn, Michael; Slade, Ingrid; Upadhyaya, Sheela; Sheehan, Mark.

Cost Eff Resour Alloc ; 17: 20, 2019.

Artigo em Inglês | MEDLINE | ID: mdl-31572067

7.

Patient and public involvement: Two sides of the same coin or different coins altogether?

McCoy, Matthew S; Warsh, Jonathan; Rand, Leah; Parker, Michael; Sheehan, Mark.

Bioethics ; 33(6): 708-715, 2019 07.

Artigo em Inglês | MEDLINE | ID: mdl-30957902

8.

National Standards for Public Involvement in Research: missing the forest for the trees.

McCoy, Matthew S; Jongsma, Karin Rolanda; Friesen, Phoebe; Dunn, Michael; Neuhaus, Carolyn Plunkett; Rand, Leah; Sheehan, Mark.

J Med Ethics ; 44(12): 801-804, 2018 12.

Artigo em Inglês | MEDLINE | ID: mdl-30337451

9.

Congress' Misguided Plan to Ban QALYs.

Rand, Leah Z; Raymakers, Adam; Rome, Benjamin N.

JAMA ; 329(24): 2125-2126, 2023 06 27.

Artigo em Inglês | MEDLINE | ID: mdl-37289466

10.

Limitations on the Capability of the FDA to Advise.

Rand, Leah Z; Kesselheim, Aaron S.

Am J Bioeth ; 22(10): 15-17, 2022 10.

Artigo em Inglês | MEDLINE | ID: mdl-36170080

11.

Power and limitations of daily prognostications of death in the medical ICU for outcomes in the following 6 months.

Meadow, William; Pohlman, Anne; Reynolds, Dan; Rand, Leah; Correia, Camil; Christoph, Ella; Hall, Jesse.

Crit Care Med ; 42(11): 2387-92, 2014 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-25072755

12.

Leah Z. Rand, Daniel P. Carpenter, Aaron S. Kesselheim, Anushka Bhaskar, Jonathan J. Darrow, and William B. Feldman Reply.

Rand, Leah Z; Carpenter, Daniel P; Kesselheim, Aaron S; Bhaskar, Anushka; Darrow, Jonathan J; Feldman, William B.

Hastings Cent Rep ; 54(2): 44-45, 2024 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-38639164

13.

Trust in the Food and Drug Administration: A National Survey Study.

Feldman, William B; Rand, Leah Z; Carpenter, Daniel; Russo, Massimiliano; Bhaskar, Anushka; Lu, Zhigang; Campbell, Eric G; Darrow, Jonathan; Kesselheim, Aaron S.

Clin Pharmacol Ther ; 2024 May 16.

Artigo em Inglês | MEDLINE | ID: mdl-38757305

14.

Alternatives to the quality-adjusted life year: How well do they address common criticisms?

Rand, Leah Z; Melendez-Torres, G J; Kesselheim, Aaron S.

Health Serv Res ; 58(2): 433-444, 2023 04.

Artigo em Inglês | MEDLINE | ID: mdl-36537647

15.

Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines.

Rand, Leah Z; Carpenter, Daniel P; Kesselheim, Aaron S; Bhaskar, Anushka; Darrow, Jonathan J; Feldman, William B.

Hastings Cent Rep ; 53 Suppl 2: S60-S68, 2023 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-37963051

16.

We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment.

Charlton, Victoria; DiStefano, Michael; Mitchell, Polly; Morrell, Liz; Rand, Leah; Badano, Gabriele; Baker, Rachel; Calnan, Michael; Chalkidou, Kalipso; Culyer, Anthony; Howdon, Daniel; Hughes, Dyfrig; Lomas, James; Max, Catherine; McCabe, Christopher; O'Mahony, James F; Paulden, Mike; Pemberton-Whiteley, Zack; Rid, Annette; Scuffham, Paul; Sculpher, Mark; Shah, Koonal; Weale, Albert; Wester, Gry.

Health Econ Policy Law ; : 1-21, 2023 Sep 27.

Artigo em Inglês | MEDLINE | ID: mdl-37752732

17.

What Should US Policymakers Learn From International Drug Pricing Transparency Strategies?

Nagar, Sarosh; Rand, Leah Z; Kesselheim, Aaron S.

AMA J Ethics ; 24(11): E1083-1090, 2022 11 01.

Artigo em Inglês | MEDLINE | ID: mdl-36342492

18.

Getting the Price Right: Lessons for Medicare Price Negotiation from Peer Countries.

Rand, Leah Z; Kesselheim, Aaron S.

Pharmacoeconomics ; 40(12): 1131-1142, 2022 12.

Artigo em Inglês | MEDLINE | ID: mdl-36348153

19.

High-Priced Sickle Cell Gene Therapies Threaten to Exacerbate US Health Disparities and Establish New Pricing Precedents for Molecular Medicine.

Tessema, Frazer A; Sarpatwari, Ameet; Rand, Leah Z; Kesselheim, Aaron S.

J Law Med Ethics ; 50(2): 380-384, 2022.

Artigo em Inglês | MEDLINE | ID: mdl-35894560

20.

Controversy Over Using Quality-Adjusted Life-Years In Cost-Effectiveness Analyses: A Systematic Literature Review.

Rand, Leah Z; Kesselheim, Aaron S.

Health Aff (Millwood) ; 40(9): 1402-1410, 2021 09.

Artigo em Inglês | MEDLINE | ID: mdl-34495724

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Payments for research participation: Don't tax the Guinea pig.

International Reference Pricing for Prescription Drugs in the United States: Administrative Limitations and Collateral Effects.

The ethics of grandfather clauses in healthcare resource allocation.

Public involvement in the governance of population-level biomedical research: unresolved questions and future directions.

The Value of the Quality-Adjusted Life Years.

Understanding and using patient experiences as evidence in healthcare priority setting.

Patient and public involvement: Two sides of the same coin or different coins altogether?

National Standards for Public Involvement in Research: missing the forest for the trees.

Congress' Misguided Plan to Ban QALYs.

Limitations on the Capability of the FDA to Advise.

Power and limitations of daily prognostications of death in the medical ICU for outcomes in the following 6 months.

Leah Z. Rand, Daniel P. Carpenter, Aaron S. Kesselheim, Anushka Bhaskar, Jonathan J. Darrow, and William B. Feldman Reply.

Trust in the Food and Drug Administration: A National Survey Study.

Alternatives to the quality-adjusted life year: How well do they address common criticisms?

Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines.

We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment.

What Should US Policymakers Learn From International Drug Pricing Transparency Strategies?

Getting the Price Right: Lessons for Medicare Price Negotiation from Peer Countries.

High-Priced Sickle Cell Gene Therapies Threaten to Exacerbate US Health Disparities and Establish New Pricing Precedents for Molecular Medicine.

Controversy Over Using Quality-Adjusted Life-Years In Cost-Effectiveness Analyses: A Systematic Literature Review.